Secaucus, NJ—The Martin Bauer Group (MBG) announced the acquisition of BI Nutraceuticals in a press release this morning.
The release says that the investment in BI Nutraceuticals will build on MBG’s local capabilities including R&D, formulations, and manufacturing. A distinction of the MBG’s portfolio is the responsible and diversified sourcing of raw materials with quality controls starting at the source.
Ennio Ranaboldo, CEO of MBG in North America, said in the release, “The addition of BI Nutraceuticals to our Group buttresses our commitment to reliable, quality, safe and clean label raw materials, meeting an increasing demand from our customers and consumers.”
George Pontiakos, president and CEO of BI Nutraceuticals, said in the release, “We are thrilled to be a part of the nature network and the Martin Bauer Group. This represents a significant move forward for us and our combined customer base. BI Nutraceuticals will now have access to the global resources of the Martin Bauer Group in the areas of raw materials sourcing, processing technology, liquid extract production, and research and development. As part of the MBG, we become a true single source solution provider.”
The release noted that the two companies will continue to operate independently.